DXCM Latest Headlines

Dexcom’s $750 Million 2025 Buyback Plan Faces Uncertain Execution and Limited Assurance of Shareholder Value

at www.tipranks.com (Sat, 14-Feb 1:00 AM)

DexCom Earnings Call Highlights Margin Rebound, Growth

at www.tipranks.com (Fri, 13-Feb 7:03 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Dexcom (DXCM) and Icon (ICLR)

at www.tipranks.com (Fri, 13-Feb 9:40 AM)

Dexcom (DXCM) Gets a Buy from Jefferies

at www.tipranks.com (Fri, 13-Feb 9:35 AM)

Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)

at www.tipranks.com (Fri, 13-Feb 9:31 AM)

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), American Well (AMWL) and Avita Medical (RCEL)

at www.tipranks.com (Fri, 13-Feb 9:10 AM)

Morgan Stanley Sticks to Its Buy Rating for Dexcom (DXCM)

at www.tipranks.com (Fri, 13-Feb 8:56 AM)

Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Vertex Pharmaceuticals (VRTX) and Royalty Pharma (RPRX)

at www.tipranks.com (Fri, 13-Feb 8:30 AM)

Stifel Nicolaus Keeps Their Buy Rating on Dexcom (DXCM)

at www.tipranks.com (Fri, 13-Feb 7:57 AM)

Piper Sandler Remains a Buy on Dexcom (DXCM)

at www.tipranks.com (Fri, 13-Feb 7:46 AM)

Analysts’ Top Healthcare Picks: Bio-Rad Laboratories (BIO), Vertex Pharmaceuticals (VRTX)

at www.tipranks.com (Fri, 13-Feb 7:30 AM)

Analysts Conflicted on These Healthcare Names: Rezolute (RZLT), Dexcom (DXCM) and Bruker (BRKR)

at www.tipranks.com (Fri, 13-Feb 7:20 AM)

Dexcom Delivers Robust 2025 Revenue Growth and Sets Sights on Higher Margins for 2026

Market Chameleon (Mon, 12-Jan 9:15 AM)